Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wendan Ningxin Granules is a Traditional Chinese Medicine (TCM) herbal formula prepared in granule form. It is indicated for the treatment of heart and gallbladder qi deficiency syndrome (心胆气虚证), which manifests with symptoms such as insomnia, restless sleep, easy awakening, palpitations, chest tightness, shortness of breath, dizziness, and spontaneous sweating. The formula aims to warm the gallbladder, tonify qi, calm the heart, and tranquilize the mind. Modern research on related TCM formulas, such as Wendan Tang and Wendan decoction granules, suggests potential anti-inflammatory, neuroprotective, and cardiovascular regulatory effects. The drug is manufactured by China Academy of Chinese Medical Sciences Guang'anmen Hospital.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wendan Ningxin Granules.